Article Information
History
- October 16, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ivan Pourmira,b,c,§,
- Nadine Benhamoudaa,d,*,
- Thi Trana,*,
- Hugo Rouxe,*,
- Joséphine Pineaua,d,
- Alain Geya,d,
- Andyara Munozd,
- Nesrine Mabroukd,
- Nicolas Epaillardf,
- Virginie Verkarreg,
- Yann-Alexandre Vanoh,i,
- Eric Tartoura,d,§┼ and
- Stéphane Oudarda,b,§┼
- aUniversité Paris Cité, INSERM U970, PARCC, Paris, France
- bMedical Oncology Department, Georges Pompidou European Hospital, Paris CARPEM Cancer Institute, AP-HP centre, Université Paris Cité.
- cThoracic Oncology Department, Georges Pompidou European Hospital, Paris CARPEM Cancer Institute, AP-HP centre, Université Paris Cité.
- dImmunology Department, Georges Pompidou European Hospital, AP-HP centre, Université Paris Cité, Paris, France
- eInstitut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France
- fMedical Oncology Department, Clinique Kuindo Magnin, Nouméa, Nouvelle Calédonie, France
- gPathology Department, Georges Pompidou European Hospital, AP-HP centre, Université Paris Cité, INSERM UMR970, Equipe Labellisée Ligue contre le Cancer, Paris, France
- hMedical Oncology Department, Hôpital Foch, Suresnes, France
- iCentre de Recherche des Cordeliers, INSERM1138, Inflammation Complément et Cancer, Université Paris Cité, Paris, France
- ↵§Corresponding authors: Paris – Cardiovascular Research Center, European Georges Pompidou Hospital, 56 rue Leblanc, 75015 PARIS, FRANCE, Phone number: +33 1 53 98 80 00, E-mail addresses: ivan.pourmir{at}aphp.fr (I. Pourmir); eric.tartour{at}inserm.fr (E. Tartour); stephane.oudard{at}aphp.fr (S. Oudard)
Posted October 16, 2024.
Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma
